The global cell therapy growth factor market size accounted for USD 668 million in 2024 and is expected to exceed around USD 1,389.63 million by 2034, growing at a CAGR of 7.6% from 2024 to 2034.
The rise in chronic diseases around the world is expected to drive the growth of the cell therapy growth factor market in the coming years. Cell therapies are a promising treatment and have the potential to transform the lives of people living with chronic diseases such as cancer, diabetes, autoimmune diseases, and others. Cell therapies have given meaningful benefits to some patients living with cancer, solid tumors, and autoimmune diseases. Several researchers are increasingly focusing on discovering more about the potential uses of cell therapy to treat various medical ailments.
The surge in cell therapies by regulatory agencies such as the FDA (Food and Drug Administration) and EMA (European Medicines Agency) to manage chronic diseases, offers significant growth opportunities to the market.
According to the IQVIA report in March 2024:
Published by Laxmi Narayan
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
| Stats ID: | 7803 |
| Format: | Databook |
| Published: | January 2025 |
| Delivery: | Immediate |
| Price | US$ 1550 |
| Stats ID: | 7803 |
| Format: | Databook |
| Published: | January 2025 |
| Delivery: | Immediate |
| Price | US$ 1550 |
Unlock unlimited access to all exclusive market research reports, empowering your business.
Get industry insights at the most affordable plan
Stay ahead of the competition with comprehensive, actionable intelligence at your fingertips!
Learn More
Download
Order Databook
Actionable Solutions
